Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

This is a randomized controlled crossover trial evaluating the efficacy of NeoThelium FT in conjunction with standard of care vs. standard of care alone in treating diabetic foot ulcers.

NCT Number	NCT06938685
Lead Sponsor	NuScience Medical Biologics, LLC Collaborators: SygNola, LLC
Conditions	Diabetic Foot Ulcer
Enrollment	132 participants
Start Date	2025-10-06
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-17